Immix Biopharma, Inc. (IMMX)

Last Closing Price: 7.11 (2026-11-18)

Earnings per Share (EPS) (Diluted) (Quarterly)

Earnings per Share (EPS) (Diluted): A company's net earnings or losses attributable to common shareholders per diluted share basis, which includes all convertible securities and debt, options and warrants.

Immix Biopharma, Inc. (IMMX) had Earnings per Share (EPS) (Diluted) of $-0.19 for the most recently reported fiscal quarter, ending 2026-09-30.

Figures for fiscal quarter ending 2026-09-30
Income Statement Financials
--
$-13.93M
--
--
$15.95M
$-15.95M
$2.02M
$-13.93M
$-13.93M
$-13.93M
$-13.93M
$-13.93M
$-13.93M
$-15.95M
$-15.83M
74.09M
74.09M
$-0.19
Earnings per Share (EPS) (Diluted)
$-0.19
Balance Sheet Financials
$338.08M
$2.41M
$7.87M
$345.95M
$10.03M
--
$0.87M
$10.89M
$335.06M
$335.06M
$335.06M
83.81M
Cash Flow Statement Financials
$-33.87M
$-14.16M
$274.41M
$93.93M
$320.32M
$226.39M
$2.84M
--
--
Fundamental Metrics & Ratios
33.72
--
--
--
--
--
--
--
--
--
--
$-34.05M
--
--
--
--
--
--
--
-4.16%
-4.16%
-4.03%
-4.16%
$4.00
$-0.46
$-0.46